7 completed, 1 unknown. 8 Phase 1, 1 Phase 2.
By phase and status
Follow elsulfavirine: new trials by email Literature Review of elsulfavirine trials Research Report on elsulfavirine
Trials (filtered) newest first · largest first
All 8 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects
Elsulfavirine - HIV-1-infection | Phase 1 | Completed | 24 | 2022-04-12 | 2023-02-21 |
An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers
Elsulfavirine - Covid19, HIV-1-infection | Phase 1 | Completed | 15 | 2021-01-23 | 2021-12-09 |
Open Labelled, Randomized Study to Evaluate the Efficacy, Safety and Dose Selection of VM-1500A-LAI Drug in HIV-infected Patients Transferred From Previous Stable Therapy (NNRTI + 2NRTI), Including ELPIDA®
VM-1500A-LAI, ELPIDA® - HIV-1-infection | Phase 1 / Phase 2 | Completed | 36 | 2021-01-19 | 2022-01-11 |
Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers
Elpida, placebo - HIV Infections | Phase 1 | Unknown | 24 | 2019-05-01 | 2019-05-20 |
Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers
Elpida - HIV Infections | Phase 1 | Completed | 36 | 2018-12-18 | 2022-01-24 |
Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs
Elpida®, Rifampin, Rifabutin - HIV-1-infection | Phase 1 | Completed | 56 | 2018-11-14 | 2022-01-26 |
Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs
Elpida®, Dolutegravir, Sofosbuvir - HIV-1-infection, Hepatic Impairment | Phase 1 | Completed | 36 | 2018-10-01 | 2022-01-11 |
Comparative Study of PK and BE of VM-1500FDC (Fixed-dose Combination) and Elpida® With Truvada® сo-administrated 1 Daily Fasting in Healthy Subjects
VM-1500FDC, Elpida®, Truvada® - HIV-1-infection | Phase 1 | Completed | 140 | 2018-06-01 | 2018-10-30 |
Conditions studied
HIV Infections (2) · Acquired Immunodeficiency Syndrome (1) · COVID-19 (1)
Sponsors
Viriom (8)
Countries
Russia (6) · Thailand (1) · United States (1)
Top investigators
Alla Andreeva, PhD (2) · Anastasia Pokrovskaya, PhD (1) · Brett Smith, MD, PhD (1) · Elena Mazygula, PhD (1) · Elena Smolyarchuk, MD, PhD (1) · Elena Smolyarchuk, PhD (1) · Irina Rodyukova, PhD (1) · Somruedee Chatsiricharoenkul, Assoc. Prof., MD (1)